Screening Hepatitis Positive Women for Congenital Anomalies

Screening Hepatitis Positive Women for Congenital Anomalies During Pregnancy and Assessment of Liver Status of Women

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03980301

Enrollment

200

Registered

2019-06-10

Start date

2018-10-11

Completion date

2020-10-20

Last updated

2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C

Brief summary

Hepatitis C virus is one of the virulent viruses

Detailed description

Hepatitius positive women should be screened for congenital anomalies

Interventions

DIAGNOSTIC_TESTultrasound

screening of pregnant women with hepatitis c virus received treatment in first trimester for congenital anomalies

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* Pregnant women with hepatitis C virus received treatment during first trimester

Exclusion criteria

* pregnant women with hepatitis C virus who didnot receive treatment during first trimester

Design outcomes

Primary

Measure	Time frame	Description
the number of pregnant women who will be diagnosed to have fetuses with congenital anomalies	within 6 months	the number of pregnant women who will be diagnosed to have fetuses with congenital anomalies by us

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026